8158 On Other Exchanges
Symbol
Exchange
8158 is not on other exchanges.

china regenerative medicine (8158) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA REGENERATIVE MEDICINE (8158)

Related News

No related news articles were found.

china regenerative medicine (8158) Related Businessweek News

No Related Businessweek News Found

china regenerative medicine (8158) Details

China Regenerative Medicine International Limited, an investment holding company, engages in the research and development of bio-medical and healthcare products, and medical techniques in the People's Republic of China. It operates through Tissue Engineering, Stem Cell, Cosmetic and Health Products, and Medical Products and Equipment segments. The company offers ActivSkin, a tissue-engineered skin product; Acellular Corneal Stroma for use in the treatment of ophthalmology; Calcined Bovine Bone, a protein-detracted natural bone regenerative product and a bone substitute material for inducing natural bone regeneration; and Acellular Small Intestinal Submucosa, which is applied to anal fistula disease. It is also involved in the research and development of Recombinant Human Acellular Dermal Matrix that is targeted and applied for second degree burns; Selective Acellular Skin for use as wound dressings; Acellular Amniotic Membrane, an anti-adhesion agent for muscle and tender rebuilding operations; and Absorbable Dental Membrane for jawbone defect restoration, which are in Stage II business development process. In addition, the company provides Cell Sheet-Autologous Chondrocyte Implantation, a medical technique for repairing knee and other relevant cartilage damages; and produces and sells cellular and stem cell therapy products. Further, it develops a series of cosmetic products and stem cell based anti-aging products; and offers contract research organization services of drug screening, drug efficacy, and toxicity assays in the pre-clinical drug development, as well as trades in medical products and equipment. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Wanchai, Hong Kong.

520 Employees
Last Reported Date: 07/15/16
Founded in 1995

china regenerative medicine (8158) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: $1.2M
Compensation as of Fiscal Year 2015.

china regenerative medicine (8158) Key Developments

China Regenerative Medicine International Limited Announces Resignation of Cao Fushun as Non-Executive Director

The board of directors of China Regenerative Medicine International Limited announced that Mr. Cao Fushun tendered his resignation as non-executive Director with effect from July 18, 2016. Due to his personal commitments on other business.

China Regenerative Medicine International Limited Reports Audited Consolidated Earnings Results for the Year Ended April 30, 2016

China Regenerative Medicine International Limited reported audited consolidated earnings results for the year ended April 30, 2016. For the period, the company reported revenue of HKD 27,751,000 compared to HKD 2,817,000 for the same period a year ago. Loss before income tax was HKD 191,198,000 compared to HKD 272,528,000 for the same period a year ago. Loss for the year was HKD 194,524,000 compared to HKD 255,392,000 a year ago. Loss for the year attributable to owners of the company was HKD 190,902,000 compared to HKD 250,098,000 for the same period a year ago. Basic loss per share was 1.103 cents compared to 2.017 cents a year ago.

China Regenerative Medicine International Limited to Report Fiscal Year 2016 Final Results on Jul 15, 2016

China Regenerative Medicine International Limited announced that they will report fiscal year 2016 final results on Jul 15, 2016

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

8158 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8158.
View Industry Companies
 

Industry Analysis

8158

Industry Average

Valuation 8158 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 186.9x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 114.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHINA REGENERATIVE MEDICINE, please visit www.crmi.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.